Paralisia de Bell

Referências

Principais artigos

Gronseth GS, Paduga R; American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy. Neurology. 2012 (reaffirmed 2023) Nov 27;79(22):2209-13.Texto completo  Resumo

Madhok VB, Gagyor I, Daly F, et al. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2016;(7):CD001942.Texto completo  Resumo

Gagyor I, Madhok VB, Daly F, et al. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2019 Sep 5;9:CD001869.Texto completo  Resumo

Gantz BJ, Rubinstein JT, Gidley P, et al. Surgical management of Bell palsy. Laryngoscope. 1999 Aug;109(8):1177-88. Resumo

Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg. 2013 Nov;149(3 Suppl):S1-27.Texto completo  Resumo

Artigos de referência

1. Peitersen E. The natural history of Bell palsy. Am J Otol. 1982 Oct;4(2):107-11. Resumo

2. Dong SH, Jung AR, Jung J, et al. Recurrent Bell's palsy. Clin Otolaryngol. 2019 May;44(3):305-12. Resumo

3. Peitersen E. Bell palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002;(549):4-30. Resumo

4. Jowett N, Hadlock TA. Contemporary management of Bell palsy. Facial Plast Surg. 2015 Apr;31(2):93-102. Resumo

5. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985 Apr;93(2):146-7. Resumo

6. Ross BG, Fradet G, Nedzelski JM. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg. 1996 Mar;114(3):380-6. Resumo

7. Banks CA, Bhama PK, Park J, et al. Clinician-graded electronic facial paralysis assessment: the eFACE. Plast Reconstr Surg. 2015 Aug;136(2):223e-30e. Resumo

8. Malka R, Miller M, Guarin D, et al. Reliability between in-person and still photograph assessment of facial function in facial paralysis using the eFACE facial grading system. Facial Plast Surg Aesthet Med. 2021 Sep;23(5):344-49.Texto completo  Resumo

9. Banks CA, Jowett N, Hadlock TA. Test-retest reliability and agreement between in-person and video assessment of facial mimetic function using the eFACE facial grading system. JAMA Facial Plast Surg. 2017 May 1;19(3):206-11.Texto completo  Resumo

10. Zaidman M, Novak CB, Borschel GH, et al. Assessment of eye closure and blink with facial palsy: a systematic literature review. J Plast Reconstr Aesthet Surg. 2021 Jul;74(7):1436-45. Resumo

11. Benatar M, Edlow J. The spectrum of cranial neuropathy in patients with Bell's palsy. Arch Intern Med. 2004 Nov 22;164(21):2383-5. Resumo

12. May M, Hardin WB, Sullivan J, et al. Natural history of Bell palsy: the salivary flow test and other prognostic indicators. Laryngoscope. 1976 May;86(5):704-12. Resumo

13. Hauser WA, Karnes WE, Annis J, et al. Incidence and prognosis of Bell palsy in the population of Rochester, Minnesota. Mayo Clin Proc. 1971 Apr;46(4):258-64. Resumo

14. Yanagihara N. Incidence of Bell palsy. Ann Otol Rhinol Laryngol. 1988 Nov-Dec;137:3-4. Resumo

15. Evangelista V, Gooding MS, Pereira L. Bell's palsy in pregnancy. Obstet Gynecol Surv. 2019 Nov;74(11):674-8. Resumo

16. Fuzi J, Spencer S, Seckold E, et al. Bell's palsy during pregnancy and the post-partum period: a contemporary management approach. Am J Otolaryngol. 2021 May-Jun;42(3):102914. Resumo

17. Gaudin RA, Remenschneider AK, Phillips K, et al. Facial palsy after dental procedures - Is viral reactivation responsible? J Craniomaxillofac Surg. 2017 Jan;45(1):71-5. Resumo

18. Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124(Part 1):27-30. Resumo

19. Esaki S, Yamano K, Katsumi S, et al. Facial nerve palsy after reactivation of herpes simplex virus type 1 in diabetic mice. Laryngoscope. 2015 Apr;125(4):E143-8. Resumo

20. Kisaki H, Hato N, Mizobuchi M, et al. Role of T-lymphocyte subsets in facial nerve paralysis owing to the reactivation of herpes simplex virus type 1. Acta Otolaryngol. 2005 Mar;125(3):316-21. Resumo

21. Gorodezky C, Carranza JM, Bustamante A, et al. The HLA system and T-cell subsets in Bell palsy. Acta Otolaryngol. 1991;111(6):1070-4. Resumo

22. Tekgul H, Polat M, Serdaroglu G, et al. Lymphocyte subsets in Bell palsy: immune pathogenesis and outcome prediction. Pediatr Neurol. 2004 Oct;31(4):258-60. Resumo

23. Alshami S, Hodge D, Bradley E, The epidemiology and surgical outcomes of facial nerve palsy in a population-based cohort. Invest. Ophthalmol. Vis. Sci. 2017 June;58(8):3848.Texto completo

24. Gupta S, Jawanda MK. Surge of Bell's palsy in the era of COVID-19: systematic review. Eur J Neurol. 2022 Aug;29(8):2526-43.Texto completo  Resumo

25. Estakhr M, Tabrizi R, Ghotbi Z, et al. Is facial nerve palsy an early manifestation of COVID-19? A literature review. Am J Med Sci. 2022 Sep;364(3):264-73.Texto completo  Resumo

26. Gupta S, Jawanda MK, Taneja N, et al. A systematic review of Bell's Palsy as the only major neurological manifestation in COVID-19 patients. J Clin Neurosci. 2021 Aug;90:284-92. Resumo

27. Shafiq A, Salameh MA, Laswi I, et al. Neurological immune-related adverse events after COVID-19 vaccination: a systematic review. J Clin Pharmacol. 2022 Mar;62(3):291-303.Texto completo  Resumo

28. Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2022 Jan;43(1):3-40.Texto completo  Resumo

29. Cirillo N, Doan R. The association between COVID-19 vaccination and Bell's palsy. Lancet Infect Dis. 2022 Jan;22(1):5-6. Resumo

30. Shemer A, Pras E, Einan-Lifshitz A, et al. Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngol Head Neck Surg. 2021 Aug 1;147(8):739-43.Texto completo  Resumo

31. Townsend JJ, Collins PK. Peripheral nervous system demyelination with herpes simplex virus. J Neuropathol Exp Neurol. 1986 Jul;45(4):419-25. Resumo

32. Fisch U. Surgery for Bell's palsy. Arch Otolaryngol. 1981 Jan;107(1):1-11. Resumo

33. Mutsch M, Zhou W, Rhodes P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell palsy in Switzerland. N Engl J Med. 2004 Feb 26;350(9):896-903. Resumo

34. Holland NJ, Weiner GM. Recent developments in Bell's palsy. BMJ. 2004 Sep 4;329(7465):553-7.Texto completo  Resumo

35. Brandenburg NA, Annegers JF. Incidence and risk factors for Bell palsy in Laredo, Texas: 1974-1982. Neuroepidemiology. 1993;12(6):313-25. Resumo

36. Abraham-Inpijn L, Devriese PP, Hart AA. Predisposing factors in Bell palsy: a clinical study with reference to diabetes mellitus, hypertension, clotting mechanism and lipid disturbance. Clin Otolaryngol Allied Sci. 1982 Apr;7(2):99-105. Resumo

37. Gilden DH. Clinical practice. Bell's palsy. N Engl J Med. 2004 Sep 23;351(13):1323-31. Resumo

38. Gilden D, Cohrs RJ, Mahalingam R, et al. Neurological disease produced by varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol. 2010;342:243-53.Texto completo  Resumo

39. Chweya CM, Anzalone CL, Driscoll CLW, et al. For whom the Bell's toll: recurrent facial nerve paralysis, a retrospective study and systematic review of the literature. Otol Neurotol. 2019 Apr;40(4):517-28. Resumo

40. Pacheco A, Rutler O, Valenzuela I, et al. Positive tests for Lyme disease and emergency department visits for bell's palsy patients. J Emerg Med. 2020 Dec;59(6):820-7. Resumo

41. American College of Radiology. ACR appropriateness criteria: cranial neuropathy. 2022 [internet publication].Texto completo

42. Gronseth GS, Paduga R; American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy. Neurology. 2012 (reaffirmed 2023) Nov 27;79(22):2209-13.Texto completo  Resumo

43. Sullivan FM, Swan IR, Donnan PT, et al. A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell's palsy: the BELLS study. Health Technol Assess. 2009 Oct;13(47):iii-iv, ix-xi 1-130.Texto completo  Resumo

44. Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol. 2007 Apr;28(3):408-13. Resumo

45. Engström M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2008 Nov;7(11):993-1000. Resumo

46. Madhok VB, Gagyor I, Daly F, et al. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2016;(7):CD001942.Texto completo  Resumo

47. Gagyor I, Madhok VB, Daly F, et al. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2019 Sep 5;9:CD001869.Texto completo  Resumo

48. Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. 2007 Oct 18;357(16):1598-607. Resumo

49. Axelsson S, Berg T, Jonsson L, et al. Prednisolone in Bell's palsy related to treatment start and age. Otol Neurotol. 2011 Jan;32(1):141-6. Resumo

50. Axelsson S, Berg T, Jonsson L, et al. Bell's palsy - the effect of prednisolone and/or valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial. Clin Otolaryngol. 2012 Aug;37(4):283-90. Resumo

51. Berg T, Bylund N, Marsk E, et al. The effect of prednisolone on sequelae in Bell's palsy. Arch Otolaryngol Head Neck Surg. 2012 May;138(5):445-9.Texto completo  Resumo

52. Fujiwara T, Namekawa M, Kuriyama A, et al. High-dose corticosteroids for adult Bell's palsy: systematic review and meta-analysis. Otol Neurotol. 2019 Sep;40(8):1101-8. Resumo

53. Jowett N, Gaudin RA, Banks CA, et al. Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes. Laryngoscope. 2017 Jun;127(6):1451-8. Resumo

54. Jalali MM, Soleimani R, Soltanipour S, et al. Pharmacological treatments of Bell's palsy in adults: a systematic review and network meta-analysis. Laryngoscope. 2021 Jul;131(7):1615-25. Resumo

55. de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. 2009 Sep 2;302(9):985-93.Texto completo  Resumo

56. Goudakos JK, Markou KD. Corticosteroids vs corticosteroids plus antiviral agents in the treatment of Bell palsy: a systematic review and meta-analysis. Arch Otolaryngol Head Neck Surg. 2009 Jun;135(6):558-64.Texto completo  Resumo

57. Quant EC, Jeste SS, Muni RH, et al. The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ. 2009 Sep 7;339:b3354.Texto completo  Resumo

58. de Ru JA, van Benthem PP. Combination therapy is preferable for patients with Ramsay Hunt syndrome. Otol Neurotol. 2011 Jul;32(5):852-5. Resumo

59. Monsanto RD, Bittencourt AG, Bobato Neto NJ, et al. Treatment and prognosis of facial palsy on Ramsay Hunt Syndrome: results based on a review of the literature. Int Arch Otorhinolaryngol. 2016 Oct;20(4):394-400.Texto completo  Resumo

60. Gantz BJ, Rubinstein JT, Gidley P, et al. Surgical management of Bell palsy. Laryngoscope. 1999 Aug;109(8):1177-88. Resumo

61. Menchetti I, McAllister K, Walker D, et al. Surgical interventions for the early management of Bell's palsy. Cochrane Database Syst Rev. 2021 Jan 26;1:CD007468.Texto completo  Resumo

62. May M, Klein SR, Taylor FH. Idiopathic (Bell's) facial palsy: natural history defies steroid or surgical treatment. Laryngoscope. 1985 Apr;95(4):406-9. Resumo

63. Lee SY, Seong J, Kim YH. Clinical implication of facial nerve decompression in complete Bell's palsy: a systematic review and meta-analysis. Clin Exp Otorhinolaryngol. 2019 Nov;12(4):348-59.Texto completo  Resumo

64. Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg. 2013 Nov;149(3 Suppl):S1-27.Texto completo  Resumo

65. Casazza GC, Schwartz SR, Gurgel RK. Systematic review of facial nerve outcomes after middle fossa decompression and transmastoid decompression for Bell's palsy with complete facial paralysis. Otol Neurotol. 2018 Dec;39(10):1311-8. Resumo

66. Sohrab M, Abugo U, Grant M, et al. Management of the eye in facial paralysis. Facial Plast Surg. 2015 Apr;31(2):140-4.Texto completo  Resumo

67. American Academy of Ophthalmology. Management of exposure keratopathy​. Apr 2014 [internet publication].Texto completo

68. Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995 Jul;39(7):1546-53.Texto completo  Resumo

69. Borodic G, Bartley M, Slattery W, et al. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005 Jul;116(1):36-43. Resumo

70. Fuzi J, Taylor A, Sideris A, et al. Does botulinum toxin therapy improve quality of life in patients with facial palsy? Aesthetic Plast Surg. 2020 Oct;44(5):1811-9. Resumo

71. de Sanctis Pecora C, Shitara D. Botulinum toxin type A to improve facial symmetry in facial palsy: a practical guideline and clinical experience. Toxins (Basel). 2021 Feb 18;13(2).Texto completo  Resumo

72. Teixeira LJ, Valbuza JS, Prado GF, et al. Physical therapy for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2011;(12):CD006283.Texto completo  Resumo

73. Khan AJ, Szczepura A, Palmer S, et al. Physical therapy for facial nerve paralysis (Bell's palsy): an updated and extended systematic review of the evidence for facial exercise therapy. Clin Rehabil. 2022 Nov;36(11):1424-49.Texto completo  Resumo

74. Beurskens CH, Heymans PG, Oostendorp RA. Stability of benefits of mime therapy in sequelae of facial nerve paresis during a 1-year period. Otol Neurotol. 2006 Oct;27(7):1037-42. Resumo

75. Pourmomeny AA, Zadmehre H, Mirshamsi M, et al. Prevention of synkinesis by biofeedback therapy: a randomized clinical trial. Otol Neurotol. 2014 Apr;35(4):739-42. Resumo

76. Nicastri M, Mancini P, De Seta D, et al. Efficacy of early physical therapy in severe Bell's palsy: a randomized controlled trial. Neurorehabil Neural Repair. 2013 Jul-Aug;27(6):542-51. Resumo

77. Chen N, Zhou M, He L, et al. Acupuncture for Bell's palsy. Cochrane Database Syst Rev. 2010;(8):CD002914. Resumo

78. Yu Z, Shen M, Shang W, et al. Timing of acupuncture treatment in peripheral facial paralysis: a systematic review and meta-analysis. Comput Math Methods Med. 2021;2021:4221955.Texto completo  Resumo

79. Wen J, Chen X, Yang Y, et al. Acupuncture medical therapy and its underlying mechanisms: a systematic review. Am J Chin Med. 2021;49(1):1-23. Resumo

80. Zou Z. Comparison of efficacy and safety of acupuncture and moxibustion in acute phase and non-acute phase of Bell's palsy: a meta-analysis. Neuro Endocrinol Lett. 2021 Nov 30;42(7):438-45. Resumo

81. Yang LS, Zhou DF, Zheng SZ, et al. Early intervention with acupuncture improves the outcome of patients with Bell's palsy: A propensity score-matching analysis. Front Neurol. 2022;13:943453.Texto completo  Resumo

82. Holland NJ, Bernstein JM, Hamilton JW, et al. Hyperbaric oxygen therapy for Bell's palsy. Cochrane Database Syst Rev. 2012;(2):CD007288.Texto completo  Resumo

83. Racic G, Denoble PJ, Sprem N, et al. Hyperbaric oxygen as a therapy of Bell's palsy. Undersea Hyperb Med. 1997;24(1):35-8. Resumo

84. Gillman GS, Schaitkin BM, May M, et al. Bell palsy in pregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg. 2002 Jan;126(1):26-30. Resumo

85. Shmorgun D, Chan WS, Ray JG. Association between Bell's palsy in pregnancy and pre-eclampsia. QJM. 2002 Jun;95(6):359-62.Texto completo  Resumo

86. Cuenca-Martínez F, Zapardiel-Sánchez E, Carrasco-González E, et al. Assessing anxiety, depression and quality of life in patients with peripheral facial palsy: a systematic review. PeerJ. 2020;8:e10449.Texto completo  Resumo

87. Hotton M, Huggons E, Hamlet C, et al. The psychosocial impact of facial palsy: A systematic review. Br J Health Psychol. 2020 Sep;25(3):695-727.Texto completo  Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal